Literature DB >> 2298361

A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease.

H O Kangro1, S K Chong, A Hardiman, R B Heath, J A Walker-Smith.   

Abstract

Seventy-two children with chronic inflammatory bowel disease were investigated for infections with various viruses and Mycoplasma pneumoniae, Chlamydia psittaci, and Coxiella burnetii to determine whether these pathogens are associated with acute onset exacerbations. Altogether 54 infections were identified serologically, of which 23 (42.6%) were associated with exacerbations. This corresponded to 24.2% of the recorded exacerbations during the study period. The respiratory pathogens accounted for 59.3% of the infections and 43.8% of these were associated with gastrointestinal symptoms. This is consistent with the observation that up to 40% of the exacerbations were associated with symptoms of antecedent or concurrent infection, most commonly involving the respiratory tract. Rubella virus, Epstein-Barr virus, and adenovirus were associated with acute exacerbations in 5 children. Thus, common pathogens were frequently associated with exacerbations and account for a large proportion of the commonly reported symptoms of a concurrent infection. The possible causal relationship between these pathogens and exacerbation of inflammatory bowel disease is discussed. Reactivation of latent herpesviruses was identified in 4 children with active disease and indicates that the converse relationship may also occur.

Entities:  

Mesh:

Year:  1990        PMID: 2298361     DOI: 10.1016/0016-5085(90)90272-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 2.  Crohn's disease and infections: a complex relationship.

Authors:  Gert De Hertogh; Karel Geboes
Journal:  MedGenMed       Date:  2004-08-10

3.  Seasonal variations in the onset of ulcerative colitis in Japan.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Hiroaki Saito; Tetsuji Yokoyama; Tomoyoshi Shibuya; Naoto Sakamoto; Kan Uchiyama; Hiroshi Arakawa; Taro Osada; Akihito Nagahara; Sumio Watanabe; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

4.  Seasonal variation in onset and relapse of IBD and a model to predict the frequency of onset, relapse, and severity of IBD based on artificial neural network.

Authors:  Jiang Chen Peng; Zhi Hua Ran; Jun Shen
Journal:  Int J Colorectal Dis       Date:  2015-05-15       Impact factor: 2.571

5.  High prevalence of Mycoplasma pneumoniae in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls.

Authors:  W Chen; D Li; B Paulus; I Wilson; V S Chadwick
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

6.  Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.

Authors:  Adam M Berg; Aamir N Dam; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-12

7.  Seasonal Variation in Flares of Intestinal Behçet's Disease.

Authors:  Jin Ha Lee; Jae Hee Cheon; Sung Pil Hong; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

8.  Compromised neuroimmune status in rats with experimental colitis.

Authors:  Lysa Boissé; Marja D Van Sickle; Keith A Sharkey; Quentin J Pittman
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

9.  Detection of herpesvirus DNA in cottontop tamarins: no association with colitis.

Authors:  M S Smith; B F Warren; J D Fox; P E Watkins; M Hudson; R E Pounder; A J Wakefield
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

Review 10.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.